PhotoPoint SnET2 tin ethyl etiopurpurin regulatory update

MRVT submitted an NDA to the FDA for PhotoPoint photodynamic therapy to treat wet age-related macular degeneration (AMD). In two Phase III trials, the compound missed the primary endpoint of visual st...